Seizures and epilepsy in the elderly

Archives of Internal Medicine

Volumn 157, Issue 6, 1997, Pages 605-617

  Thomas, Robert J ^a,b  

^a East Tennessee State University   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; CALCIUM CHANNEL BLOCKING AGENT; CARBAMAZEPINE; CEPHALOSPORIN DERIVATIVE; CINNARIZINE; CLOBAZAM; CLONAZEPAM; CYCLOSPORIN; FELBAMATE; FLUMAZENIL; FLUNARIZINE; FOSPHENYTOIN SODIUM; GABAPENTIN; IODINATED CONTRAST MEDIUM; LAMOTRIGINE; LIDOCAINE; LITHIUM; NEUROLEPTIC AGENT; OXCARBAZEPINE; PENICILLIN DERIVATIVE; PETHIDINE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VALPROIC ACID; VIGABATRIN;

AGED; ALZHEIMER DISEASE; BRAIN TUMOR; CEREBROVASCULAR DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; COGNITIVE DEFECT; DEGENERATIVE DISEASE; DIFFERENTIAL DIAGNOSIS; ELECTROENCEPHALOGRAM; EPILEPSY; EPILEPTIC STATE; HUMAN; HYPOTENSION; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; METABOLIC DISORDER; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REVIEW; SEIZURE; VASCULAR AMYLOIDOSIS;

EID: 0030893824     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.157.6.605     Document Type: Review

References (203)

1. Hauser WA, Annegers JF, Kurland LT. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984. Epilepsia. 1993;34:453-468.
2. Scheuer ML, Cohen J. Seizures and epilepsy in the elderly. Neurol Clin. 1993;11:787-804.
3. Sanders KM, Murray GB, Geriatric epilepsy: a review. J Geriatr Psychiatry Neurol. 1991;4:98-105.
4. Dam AM, Fuglsang-Fredriksen A, Svarre-Olsen U, Dam M. Late-onset epilepsy: etiologies, types of seizure, and value of clinical investigation, EEG, and computerized tomography scan. Epilepsia. 1985;26:227-231.
5. Asconape JJ, Penry JK, Poststroke seizures in the elderly. Clin Geriatr Med. 1991;7:483-492.
6. Gupta K, Epilepsy in the elderly: how far to investigate? Br J Clin Pract. 1983;3:249-253.
7. Luhdorf K, Jensen LD, Plesner AM. Epilepsy in the elderly: prognosis. Acta Neurol Scand. 1987;74:409-415.
8. Luhdorf K, Jensen LD, Plesner AM. Etiology of seizures in the elderly. Epilepsia. 1986;27:458-464.
9. Roberts RC, Shorvon SD, Cox TCS, et al. Clinically unsuspected cerebral infarction revealed by computed tomography scanning in late-onset epilepsy. Epilepsia. 1988;29:190-197.
10. Sundaram MBM. Etiology and patterns of seizures in the elderly. Neuroepidemiology. 1989;8:234-242.
11. Sung CY, Chu NS. Epileptic seizures in elderly people: etiology and seizure type. Age Ageing. 1990;19:25-30.
12. Sung CY, Chu NS. Status epilepticus in the elderly: etiology, seizure type and outcome. Acta Neurol Scand. 1989;80:51-56.
13. Forsgren L. Prospective incidence study and clinical characterization of seizures in newly referred adults. Epilepsia. 1990;31:292-301.
14. Ettinger AB, Shinnar S. New-onset seizures in an elderly hospitalized population. Neurology. 1993;43:489-492.
15. Loiseau J, Loiseau P, Duche B, Guyot M, Dartigues J-F, Aublet B. A survey of epileptic disorders in Southwest France: seizures in elderly patients. Ann Neurol. 1990;27:232-237.
16. Forsgren L, Bucht G, Erikson S, Bergmark L. Incidence and clinical characterization of unprovoked seizures in adults: a prospective population-based study. Epilepsia. 1996;37:224-229.
17. de la Court A, Breteler MMB, Meinardi H, Hauser WA, Holman A. Prevalence of epilepsy in the elderly: the Rotterdam Study. Epilepsia. 1996;37:141-147.
18. Hauser WA. Seizure disorders: the changes with age. Epilepsia. 1992;33(suppl 4):S6-S14.
19. Tallis R, Hall G, Craig I, Dean A. How common are epileptic seizures in old age? Age Ageing. 1991;20:442-448.
20. Scheuer ML. Medical aspects of managing seizures and epilepsy. In: Pedley TA, Meldrum BS, eds. Recent Advances in Epilepsy. New York, NY: Churchill Livingstone Inc; 1992:127-143.
21. Tatemichi TK, Young WL, Prohovnik I, et al. Perfusion insufficiency in limb-shaking transient ischemic attacks. Stroke. 1990;21:341-347.
22. Baquis GD, Pessin MS, Scott RM. Limbshaking: a carotid TIA. Stroke. 1985;16:444-448.
23. Yanagihara T, Piepgras DG, Klass DW. Repetitive involuntary movement associated with episodic cerebral ischemia. Ann Neurol. 1985;18:244-250.
24. Chamorro A, Vila N, Alday M, Saiz A. Limb shaking and loss of consciousness: a carotid-basilar artery syndrome. Neurologia. 1995;10:49-52.
25. Lee H, Lerner A. Transient inhibitory seizures mimicking crescendo TIAs. Neurology. 1990;40:165-166.
26. Fischer CM. Transient paralytic attacks of obscure nature: the question of non-convulsive seizure paralysis. Can J Neurol Sci. 1978;5:267-273.
27. Drury I, Beydoun A. Pitfalls of EEG interpretation in epilepsy. Neurol Clin. 1993;11:857-881.
28. van Donselaar CA, Schimsheimer R-J, Geerts AT, Declerck AC. Value of the electroencephalogram in adult patients with untreated idiopathic first seizures. Arch Neurol. 1992;49:31-37.
29. Luhdorf K, Jensen LD, Plesner AM. The value of EEG in the investigation of postapoplectic epilepsy. Acta Neurol Scand. 1986;74:279-283.
30. Holmes GL. The electroencephalogram as a predictor of seizures following cerebral infarction. Clin Electroencephalogr. 1980;11:83-87.
31. Kilpatrick CJ, Davis SM, Tress BM, Rossiter SC, Hopper JL, Vandendriesen ML. Epileptic seizures in acute stroke. Arch Neurol. 1990;47:157-160.
32. Daly DD, Markand ON. Focal brain lesions. In: Daly DD, Pedley TA, eds. Current Practice of Clinical Electroencephalography, New York, NY: Raven Press; 1990:335-470.
33. Quesney LF, Constain M, Rasmussen T, Oliver A, Palmini A. Presurgical EEG investigation in frontal lobe epilepsy. Epilepsy Res. 1992;5 (Suppl):55-69.
34. Blume MT, Pillay N. Electrographic and clinical correlates of secondary bilateral synchrony. Epilepsia. 1985;26:636-641.
35. Gras P, Grosmaire N, Solchot P, Giroud M, Dumas R. EEG periodic lateralized activities associated with ischemic cerebrovascular strokes: physlopathological significance and localizing value. Neurophysiol Clin. 1991;21:293-299.
36. Wheless JW, Holmes GL, King DW, et al. Possible relationship of periodic lateralized epileptiform discharges to thalamic stroke. Clin Electroencephalogr, 1991;22:211-216.
37. Brenner RP, Schaul N. Periodic EEG patterns: classification, clinical correlation, and pathophysiology. J Clin Neurophysiol. 1990;7:249-267,
38. Walsh JM, Brenner RP. Periodic lateralized epileptiform discharges: long term outcome in adults. Epilepsia. 1987;28:533-536.
39. Byrne TN. Imaging of gliomas. Semin Oncol. 1994;21:162-171.
40. Yue NC. Advances in brain tumor imaging. Curr Opin Neurol. 1993;6:831-840.
41. Baron JC. Neuroimaging procedures in acute ischemic stroke. Curr Opin Neurol. 1993;6:900-904.
42. Nelson M, Bartlett RJV, Lamb JT. Seizures after intravenous contrast media for cranial computed tomography. J Neurol Neurosurg Psychiatry. 1989;52:1170-1175.
43. Avrahami E, Weiss-Peretz J, Cohn DF, Focal epileptic activity following intravenous contrast material injection in patients with metastatic brain disease. J Neurol Neurosurg Psychiatry, 1987;50:221-223.
44. Sperling MR. Neuroimaging in epilepsy: recent developments in MR imaging, positron-emission tomography, and single-photon emission tomography. Neurol Clin. 1993;11:883-903.
45. Abou-Khalil BW, Siegel GJ, Sackellares JC, et al. Positron emission tomography studies of cerebral glucose metabolism in chronic partial epilepsy. Ann Neurol. 1987;22:480-488.
46. Markand ON, Salanova V, Worth RM, Park HM, Wellman HH. Ictal brain imaging in presurgical evaluation of patients with medically intractable complex partial seizures. Acta Neurol Scand. 1994;152(suppl):137-144.
47. Duncan R, Pattersson J, Roberts R, Hadley DM, Bone I. Ictal/postictal SPECT in the presurgical localization of complex partial seizures. J Neurol Neurosurg Psychiatry. 1993;56:141-148.
48. Spencer SS. The relative contributions of MRI, SPECT, and PET imaging in epilepsy. EpilepSia. 1994;35(suppl 6):S72-S89.
49. Barnstein P, Ludolph A. Schober O, et al. Benzodiaepine receptors and cerebral blood flow in partial epilepsy. Eur J Nucl Med. 1991;18:111-118.
50. Heiss WO, Podreka I. Role of PET and SPECT in the assessment of ischemic cerebrovascular disease. Cerebrovasc Brain Metab Rev. 1993;5:235-263.
51. Davis PC, Mirra SS, Alazraki N. The brain in older persons with and without dementia: findings on MR, PET, and SPECT images. AJR Am J Roentgenol. 1994;162:1267-1278.
52. McKeith IG, Bartholomew PH, Irvine EM, Cook J, Adams R, Simpson AE. Single photon emission computerized tomography in elderly patients with Alzheimer's disease and multi-infarct dementia: regional uptake of technetium-labelled HMPAO related to clinical measurements. Br J Psychiatry. 1993;163:597-603.
53. Claus JJ, van Harskamp F, Breteler MM, et al. The diagnostic value of SPECT with Tc 99m HMPAO in Alzheimer's disease: a population-based study. Neurology. 1994;44:454-461.
54. Motomura N, Seo T. Lateral hemispheric asymmetries in senile dementia of Alzheimer's type (SDAT) assessed by 1-123 IMP SPECT imaging: a preliminary report. Int J Neurosci. 1992;63:1-3.
55. Jackson GO, New techniques in magnetic resonance and epilepsy. Epilepsia. 1994;35(suppl 6):S2-S13.
56. Prichard JW. Nuclear magnetic resonance spectroscopy of seizure states. Epilepsia, 1994;35 (Supp 16):S14-S20.
57. Jack CR Jr. MRI-based hippocampal volume measurements in epilepsy. Epilepsia. 1994;35 (suppl 6):S21-S29.
58. Shinton RA, Gill JS, Melnick SC, et al. The frequency, characteristics and prognosis of epileptic seizures at the onset of stroke. J Neurol Neurosurg Psychiatry, 1988;51:273-276.
59. Black SE, Norris JW, Hachinski VC, et al. Poststroke seizures. Stroke. 1983;14:134-143.
60. Shapiro IM, Neufeld MY, Korczyn AD. Seizures of unknown origin after the age of 50: vascular risk factors. Acta Neurol Scand. 1990;82:78-83.
61. Hauser WA, Ramirez-Lassepas M, Rosenstein R. Risk for seizures and epilepsy following cerebrovascular insults. Epilepsia. 1984;25:666-670.
62. Gupta SR, Naheedy MH, Elias D, et al. Postin-farction seizures: a clinical study. Stroke. 1988;19:1477-1481.
63. Fish DR, Miller DH, Roberts RC, et al, The natural history of late-onset epilepsy secondary to vascular disease. Acta Neurol Scand. 1989;89:524-531.
64. de Carolis P, D'Alessandro R, Ferrara R, Andreoll A, Sacquegna T, Lugaresi E. Late seizures in patients with internal carotid and middle cerebral artery occlusive disease following ischemic events. J Neurol Neurosurg Psychiatry. 1984;47:1345-1347.
65. Shinton RA, Gill JS, Melnick SC, Gupta AK, Severs DG. The frequency, characteristics and prognosis of epileptic seizures at the onset of stroke. J Neurol Neurosurg Psychiatry. 1988;51:272-276.
66. Shorvon SD, Gilliatt RW, Cox TCS, Yu YL. Evidence of vascular disease from CT scanning in late onset epilepsy. J Neurol Neurosurg Psychiatry. 1984;47:225-230.
67. Cocito L, Favale E, Reni L. Epileptic seizures in cerebral arterial occlusive disease. Stroke. 1982;13:189-195.
68. Kilpatrik CJ, Davis SM, Hopper JL. Rossiter SC. Early seizures after acute stroke: risk of late seizures. Arch Neurol. 1992;49:509-511.
69. Kotila M, Waltimo O. Epilepsy after stroke. Epilepsia. 1992;33:495-498.
70. Lesser RP, Luders H, Dinner DS, Morris HH. Epileptic seizures due to thrombotic and embolic cerebrovascular disease in older patients. Epilepsia. 1985;26:622-630.
71. Olsen TS, Hogenhaven H, Thage O, Epilepsy after stroke, Neurology. 1987;37:1209-1211.
72. Heuts-Van Raak EPM, Boellaard A, De Krom MCTFM, Lodder J. Supratentorial brain infarcts in adult-onset seizures: the Maastricht Epilepsy Case Register. Seizure. 1993;2:221-227.
73. Giroud M, Gras P, Fayolle H, Andre N, Soichot P, Dumas R. Early seizures after acute stroke: a study of 1640 cases. Epilepsia. 1994;35:959-964.
74. So EL, Annegers JF, Hauser WA, O'Brien PC, Whisnant JP. Population-based study of seizure disorders after cerebral infarction. Neurology. 1996;46:350-355.
75. Giroud M, Dumas R. Role of associated cortical lesions in motor partial seizures and lenticulostriate infarcts. Epilepsia. 1995;36:465-470.
76. Mayer SA, Tatemichi TK, Hair LS, Goldman JE, Camac A, Mohr JP. Hemineglect and seizures in Binswanger's disease: clinical-pathological report. J Neurol Neurosurg Psychiatry. 1993;56:816-819.
77. Hankey GJ. Prolonged exacerbation of the neurological sequelae of stroke by post-stroke partial epileptic seizures. Aust N Z J Med. 1993;23:306.
78. Bogousslavsky J, Martin R, Regli F, Despland P-A, Bolyn S. Persistent worsening of stroke sequelae after delayed seizures. Arch Neurol. 1992;49:385-388.
79. Lancman ME, Golimstok A, Norscini J, Granillo R. Risk factors for developing seizures after a stroke. Epilepsia. 1993;34:141-143.
80. Sung CY, Chu MS. Epileptic seizures in intracerebral hemorrhage. J Neurol Neurosurg Psychiatry. 1989;52:1273-1276.
81. Garde A, Bohmer G, Selden B, et al. 100 cases of spontaneous intracerebral hematoma. Eur Neurol. 1983;22:161-165.
82. Faught E, Peters D, Bartolucci A, Moore L, Miller PC, Seizures after primary intracerebral hemorrhage. Neurology. 1989;39:1089-1093.
83. Berger AR, Lipton RB, Lesser ML, Lantos G, Portenoy RK. Early seizures following intracerebral hemorrhage: implications for therapy, Neurology. 1988;38:1363-1365.
84. Sundaram MBM, How F, Seizures associated with spontaneous subarachnoid hemorrhage. Can J Neurol Sci. 1986;13:229-233.
85. Cabral RJ, King TT, Scott DF. Epilepsy after two neurosurgical approaches to the treatment of ruptured intracranial aneurysm. J Neurol Neurosurg Psychiatry. 1976;39:1052-1054.
86. Hart RG, Byer JA, Laughter JL, et al. Occurrence and implications of seizures in subarachnoid hemorrhage due to ruptured intracranial aneurysm. Neurosurgery. 1981;8:417-422.
87. Breen JC, Caplan LR, DeWitt LD, Belkin M, Mackey WC, O'Donnell TP. Brain edema after carotid surgery. Neurology. 1996;46:175-181.
88. Nielsen TG, Sillesen H, Schroeder TV. Seizures following carotid endarterectomy in patients with severely compromised cerebral circulation. Eur J Vasc Endovasc Surg. 1995;9:53-57.
89. George SM Jr, Klamer TW, Lambert GE Jr. Cerebral hyperperfusion syndrome: an etiology of seizures following carotid endarterectomy. J Ky Med Assoc. 1993;91:451-453.
90. Ettinger AB, Structural causes of epilepsy: tumors, cysts, stroke, and vascular malformations. Neurol Clin. 1994;12:41-56.
91. Black PM, Brain tumors, II. N Engl J Med. 1991;324:1555-1564.
92. Bateman DE, Hardy JA, McDermott JR, Parker DS, Edwardson JA. Amino acid neurotransmitter levels in gliomas and their relationship to the incidence of epilepsy. Neurol Res. 1988;10:112-114.
93. Haglund MM, Berger MS, Kunkel DD, Franck JE, Ghatan S, Ojemann GA. Changes in gamma-aminobutyric acid and somatostatin in epileptic cortex associated with low-grade gliomas. J Neurosurg. 1992;77:209-216.
94. Steg RE, Frank AR, Lefkowitz DM. Complex partial status epilepticus in a patient with dural metastases. Neurology. 1993;43:2389-2392.
95. Morris HH, Estes ML, Gllmore R, Van-Ness PC, Barnett GH, Turnbull J. Chronic intractable epilepsy as the only symptom of primary brain tumor. Epilepsia. 1993;34:1038-1043.
96. Delarive J, de-Tribolet N. Cerebral metastases: a study of a surgical series of 81 cases. Neurochirurgie. 1992;38:89-97.
97. Hauser WA, Morris ML, Heston LL, Anderson VE. Seizures and myoclonus in patients with Alzheimer's disease. Neurology. 1986;36:1226-1230.
98. Risse SC, Lampe TH, Bird TD, et al. Myoclonus, seizures, and paratonia in Alzheimer disease. Alzheimer Dis Assoc Disord. 1990;4:217-225.
99. Mendez MF, Catanzaro P, Doss RC, Arguello R, Frey WH 2nd. Seizures in Alzheimer's disease: clinicopathologic study. J Geriatr Psychiatry Neurol. 1994;7:230-233.
100. McAreavey MJ, Ballinger BR, Fenton GW. Epileptic seizures in elderly patients with dementia. Epilepsia. 1992;33:657-660.
101. Romanelli MF, Morris JC, Ashkin K, Coben LA. Advanced Alzheimer's disease is a risk factor for late-onset seizures. Arch Neurol. 1990;47:847-850.
102. Forstl H, Burns A, Levy R, Cairns M, Lutnert P, Lantos P. Neurological signs in Alzheimer's disease: results of a prospective clinical and neuropath ological study. Arch Neurol. 1992;49:1038-1042.
103. Volicer L, Smith S, Vollcer BJ. Effect of seizures on progression of dementia of the Alzheimer type. Dementia. 1995;6:258-263.
104. Lampe TH, Bird TD, Nochlin D, et al. Phenotype of chromosome 14-linked familial Alzheimer's disease in a large kindred. Ann Neurol. 1994;36:368-378.
105. Hesdorffer DC, Hauser WA, Annegers JF, Kokmen E, Rocca WA. Dementia and adult-onset unprovoked seizures. Neurology. 1996;46:727-730.
106. Vinters H. Cerebral amyloid angiopathy: a critical review. Stroke. 1987;18:311-324.
107. Silbert PL, Bartleson JD, Miller GM, Parisi JE, Goldman MS, Meyer FB. Cortical petechial hemorrhage, leukoencephalopathy, and subacute dementia associated with seizures due to cerebral amyloid angiopathy. Mayo Clin Proc. 1995;70:477-480.
108. Greenberg SM, Vonsattel JPG, Stakes JW, Gruber M, Finklestein SP. The clinical spectrum of cerebral amyloid angiopathy: presentations with-out lobar hemorrhage. Neurology. 1993;43:2073-2079.
109. Brick JF, Gutreht JA, Ringel RA. Reflex epilepsy and nonketotic hyperglycemia in the elderly: a specific neuroendocrine syndrome. Neurology. 1989;39:394-399.
110. Singh BM, Strobos R. Epilepsia partialis continua associated with nonketotic hyperglycemia: clinical and biochemical profile of 21 patients. Ann Neurol. 1980;8:155-160.
111. Aquino A, Gabor AJ. Movement-induced seizures in nonketotic hyperglycemia. Neurology. 1980;30:600-604.
112. Venna N, Sabin TD. Tonic focal seizures in non-ketotic hyperglycemia of diabetes mellitus. Arch Neurol. 1981;38:512-514.
113. Duckrow RB, Beard DC. Brennan RW. Regional cerebral blood flow decreases during hyperglycemia. Ann Neurol. 1985;17:267-272.
114. Vastola EF, Maccario M, Roman R. Activation of epileptogenic foci by hyperosmolarity. Neurology. 1967;17:520-526.
115. Guisado R, Arieff AI. Neurologic manifestations of diabetic comas: correlation with biochemical alterations of the brain. Metabolism. 1975;24:665-679.
116. Cascino GD, Westmoreland BF, Swanson TH, Sharbrough FW. Seizure-associated speech arrest in elderly patients. Mayo Clin Proc. 1991;66:254-258.
117. Bass E. Cardiopulmonary arrest: pathophysiology and neurological complications. Ann Intern Med. 1985;103:920-927.
118. Longstreth WT Jr. The neurological sequelae of cardiac arrest. West J Med. 1987;147:175-180.
119. Wijdicks EF, Parisi JE, Sharbrough FW. Prognostic value of myoclonus status in comatose survivors of cardiac arrest. Ann Neurol. 1994;35:239-243.
120. Young GB, Gilbert JJ, Zochodne DW. The significance of myoclonic status epilepticus in postanoxic coma. Neurology. 1990;40:1843-1848.
121. Jumaoas A, Brenner RP. Myoclonic status epilepticus: a clinical and electroencephalographic study. Neurology. 1990;40:1199-1202.
122. Garcia PA, Alldredge BK. Drug-induced seizures. Neurol Clin. 1994;12:85-99.
123. Franson KL, Hay DP, Neppe V, et al. Drug-induced seizures in the elderly: causative agents and optimal management. Drugs Aging. 1995;7:38-48.
124. Grasela TH Jr, Orels MW. An evaluation of the qulnolone-theophylline interaction using the Food and Drug Administration spontaneous reporting system. Arch Intern Med. 1992;152:617-621.
125. Bahls FH, Ma KK, Bird TD. Theophylline associated seizures with 'therapeutic' or low toxic serum concentrations: risk factors for serious outcome in adults. Neurology. 1991;41:1309-1316.
126. Mori H, Mizutani T, Yoshimura M, Yamanouchi H, Shimada M, Unilateral brain damage after prolonged hemiconvulsions in the elderly associated with theophylline administration. J Neurol Neurosurg Psychiatry. 1992;55:466-469.
127. O'Riordan JI, Hutchinson J, FitzGerald MX, Hutchinson M. Amnesic syndrome after theophylline associated seizures: iatrogenic brain injury. J Neurol Neurosurg Psychiatry. 1994;57:643-645.
128. Dragunow M. Adenosine receptor antagonism accounts for the seizure prolonging effects of aminophylline. Pharmacol Biochem Behav. 1990;36:751-759.
129. Fakhoury T, Abou-Khalil B, Newman K. Psychogenic seizures in old age: a case report. Epilepsia. 1993;34:1049-1051.
130. Boon PA, Williamson PD. The diagnosis of pseudoseizures. Clin Neurol Neurosurg. 1993;95:1-8.
131. Saygi S, Katz A, Marks DA, Spencer SS. Frontal lobe partial seizures and psychogenic seizures: comparison of clinical and ictal characteristics. Neurology. 1992;42:1274-1277.
132. Leis AA, Ross MA, Summers AK. Psychogenic seizures: ictal characteristics and diagnostic pitfalls. Neurology. 1992;42:95-99.
133. Oxbury JM, Whitty CWM. Causes and consequences of status epilepticus in adults: a study of 86 cases. Brain. 1971;94:733-744.
134. Aminoff M, Simon RP. Status epilepticus: causes, clinical features and consequences in 98 patients. Am J Med. 1980;69:657-666.
135. Rowan AJ, Scott DP, Major status epilepticus: a series of 42 patients. Acta Neurol Scand. 1970;46:573-584.
136. Celesia CG, Messert B, Murphy MJ. Status epilepticus of late adult onset. Neurology. 1972;22:1047-1055.
137. Hauser WA. Status epilepticus: frequency, etiology, and neurological sequelae. in: Delgado-Escueta AV. Wasterlain CG, Treiman DM, Porter RJ, eds. Advances in Neurology: Status Epilepticus: Mechanisms of Brain Damage and Treatment New York, NY: Raven Press; 1983;34:3-14.
138. Godfrey JBW. Misleading presentation of epilepsy in elderly people. Age Ageing. 1989;18:17-20.
139. Jaffe R. Ictal behavioral disturbances as the only manifestation of seizure disorder. J Nerv Ment Dis. 1962;134:470-476.
140. Thompson SW, Greenhouse AM. Petit mal status in adults. Ann Intern Med. 1968;68:1271-1279.
141. Wells CE. Transient ictal psychosis. Arch Gen Psychiatry. 1975;32:1201-1203.
142. Ellis JM, Lee SI. Acute prolonged confusion in later life as an ictal state. Epilepsia. 1977;19:119-128.
143. Tomson T, Lindbom U, Nilsson BY. Nonconvulsive status epilepticus in adults: thirty-two consecutive patients from a general hospital population. Epilepsia. 1992;33:829-835.
144. Dunne JW, Summers QA, Stewart-Wynne EG. Non-convulsive status epilepticus: a prospective study in an adult general hospital. Q J Med. 1987;62:117-126.
145. Iivanainen M, Bergstrom L, Nuutila A, Viukari M. Psychosis-like absence status of elderly patients: successful treatment with sodium valproate. J Neurol Neurosurg Psychiatry. 1984;47:965-969.
146. Terzano MG, Parrino L, Mazzucchi A, Moretti G. Confusional states with periodic lateralized epileptiform discharges (PLEDs): a peculiar epileptic syndrome in the elderly. Epilepsia. 1986;27:446-457.
147. Rey M, Papy JJ. A critical confusion state of frontal origin in elderly subjects: difficult diagnosis. Rev Electroencephalogr Neurophysiol Clin. 1987;17:377-385.
148. Hoch DB, Hill RA, Oas KH. Epilepsy and mental decline. Neurol Clin. 1994;12:101-113.
149. Dodrill CB, Wilensky AJ. Intellectual impairment as an outcome of status epilepticus. Neurology. 1990;40:23-27.
150. Shewmon DA, Erwin RJ. The effect of focal interictal spikes on perception and reaction time, I: general considerations, Electroencephalogr Clin Neurophysiol. 1988;69:319-337.
151. Shewmon DA, Erwin RJ, The effect of focal interictal spikes on perception and reaction time, II: neuranatomic specificity. Electroencephalogr Clin Neurophysiol. 1988;69:338-352.
152. Aarts JHP, Binnie CD, Smit AM, Wilkins AJ. Selective cognitive impairment during focal and generalized epileptiform EEG activity. Brain. 1984;107:293-308.
153. Leiderman DB, Albert P, Balish M, Bromfield E, Theodore WH. The dynamics of metabolic change following seizures as measured by positron emission tomography with fludeoxyglucose F 18. Arch Neurol. 1994;51:932-936.
154. Walker AE, Blumer D. The fate of World War II veterans with posttraumatic epilepsy. Arch Neurol. 1989;46:23-26.
155. Perrine K, Congett S. Neurobehavioral problems in epilepsy. Neurol Clin. 1994;12:129-152.
156. Trimble MR. Anticonvulsant drugs and cognitive function: a review of the literature. Epilepsia. 1987;28(suppl 3):S37-S45.
157. Smith D, Mattson R, Cramer J, et al. VA Epilepsy Cooperative Study Group: results of a nationwide Veterans Administration Cooperative Study comparing the efficacy and toxicity of carbamazepine, phenobarbital, phenytoin, and primidone. Epilepsia. 1987;28(suppl):S50-S58.
158. Meador K, Loring D, Huh K, et al. Comparative cognitive effects of anticonvulsants. Neurology. 1990;40:391-394.
159. Dodrill CB, Troupin A. Neuropsychological effects of carbamazepine and phenytoin: a reanalysis. Neurology. 1991;41:141-143.
160. Craig I, Tallis R. Impact of valproate and phenytoin on cognitive function in elderly patients: results of a single-blind randomized comparative study. Epilepsia. 1994;35:381-390.
161. Schaff MR, Fawcett J, Zajecka JM. Divalproex sodium in the treatment of refractory affective disorders. J Clin Psychiatry. 1993;54:380-384.
162. Post RM, Weiss SR, Chuang DM, Mechanisms of action of anticonvulsants in affective disorders: comparisons with lithium. J Clin Psychopharmacol. 1992;12(suppl 1);S23-S35.
163. Pulliainen V, Jokelainen M. Effects of phenytoin and carbamazepine on cognitive functions in newly diagnosed epileptic patients. Acta Neurol Scand. 1994;89:81-86.
164. Cramer JA. Quality of life for people with epilepsy. Neurol Clin. 1994;12:1-13.
165. Kendrick AM, Trimble MR. Patient-perceived quality of life: what is important to the patient with epilepsy? Seizure. 1992;1(suppl A):1-10.
166. Smith DF, Baker GA, Dewey M, et al. Seizure frequency, patient perceived seizure severity, and the psychosocial consequences of intractable epilepsy. Epilepsy Res. 1991;9:231-241.
167. Oles KS, Gal P, Penry JK, Tapscott WK. Use of antiepileptic drugs in the elderly population. Public Health Rep. 1987;102:3335-3337.
168. Cohen J, Scheuer ML. Antiepileptic drug use in elderly patients with epilepsy. Epilepsia. 1991;32(suppl 3):53.
169. Leppik IE. Metabolism of antiepileptic medications: newborn to elderly. Epilepsia. 1992;33 (suppl 4):S32-S40.
170. Leppik IE, Wolff DL, Antiepileptic medication interactions. Neurol Clin. 1993;11:905-921.
171. Mooradlan AD, Hernandez L, Tamai IC, Marshall C, Variability of serum phenytoin concentrations in nursing home patients. Arch Intern Med. 1969;149:890-892.
172. Kenneback G, Bergfeldt L, Vallin H, et al. Electrophysiologic effects and clinical hazards of carbamazepine treatment for neurological disorders in patients with abnormalities of the cardiac conduction system. Am Heart J. 1991;121:1421-1423.
173. Kenneback G, Bergfeldt L, Tomson T, Spina E, Edhag O. Carbamazepine induced bradycardia: a problem in general or only in susceptible patients? a 24-hr long-term electrocardiogram study. Epilepsy Res. 1992;13:141-145.
174. Boesen F, Anderson EB, Jensen EK, Ladefoged SD. Cardiac conduction disturbances during carbamazepine therapy. Acta Neurol Scand. 1983;68:49-52.
175. Fleisher D, Sheth N, Kou JH, Phenytoin interaction with enteral feedings administered through nasogastric tubes. J Parenter Enteral Nutr. 1990;14:513-516.
176. Haley CJ, Nelson J. Phenytoin-enteral feeding interaction. DICP. 1989;23:796-798.
177. Guidry JR, Eastwood TF, Curry SC. Phenytoin absorption in volunteers receiving selected enteral feedings. West J Med. 1989;150:658-661.
178. Mattson RH, Cramer JA, Collins JF, and the Department of Veterans Affairs Epilepsy Cooperative Study No. 264 Group. A comparison of valproate and carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults. N Engl J Med. 1992;327:765-771.
179. Richens A, Davidson DLW, Cartlidge NEF, Easter DJ, on behalf of the Adult EPITEG Collaborative Group. A multicenter comparative trial of sodium val proate and carbamazepine in adult-onset epilepsy. J Neurol Neurosurg Psychiatry. 1994;57:682-687.
180. Adams HP, Brott TG, Crowell RM, et al. Guidelines for the management of patients with acute ischemic stroke: a Statement for Healthcare Professionals From a Special Writing Group of the Stroke Council, American Heart Association. Circulation. 1994;90:1588-1601.
181. Welty TE, Horner TG. Pathophysiology and treatment of subarachnoid hemorrhage. Clin Pharm. 1990;9:35-39.
182. Lloyd P, Flesch G, Dieterle W. Clinical pharmacology and pharmacokinetics of oxcarbazepine. Epilepsia. 1994;35(suppl 3):S10-S13.
183. Baruzzi A, Albani F, Riva R, Oxcarbazepine: pharmacokinetic interactions and their clinical significance. Epilepsia. 1994:35(suppl 3):S14-S19.
184. Keranen T, Jolkkonen J, Jensen PK, Menge GP, Oxcarbazepine does not interact with cimeti- dine in healthy volunteers. Acta Neurol Scand. 1992;85:239-242.
185. Keranen T, Jolkkonen J, Jensen PK, Menge GP, Andersson P. Absence of Interaction between oxcarbazepine and erythromycin. Acta Neurol Scand. 1992;86:120-123.
186. Klosterskov Jensen P, Saano V, Haring P, Svenstrup B, Menge GP. Possible interaction between oxcarbazepine and an oral contraceptive. Epilepsia. 1992;33:1149-1152.
187. Zaccara G, Gangemi PF, Bendoni L, et al. Influence of single and repeated doses of oxcarbazepine on the pharmacokinetic profile of felodiplne. Ther Drug Monit. 1993;15:39-42.
188. Dam M. Practical aspects of oxcarbazapine treatment. Epilepsia. 1994;35(suppl 3):S233-S235.
189. Laxer KD, Guidelines for treating epilepsy in the age of felbamate, vigabatrin, lamotrigine, and gabapentin. West J Med. 1994;161:309-314.
190. Leppik IE, Graves N, Devinsky O. Newantiepileptic medications. Neurol Clin. 1993;11:923-949.
191. Goa KL, Sorkin EM. Gabapentin: a review of its pharmacological properties and clinical potential in epilepsy, Drugs. 1993;46:409-427.
192. Burstein AH. Lamotrigine. Pharmacotherapy. 1995;15:129-143.
193. Dodrill CB, Arnett JL, Sommerville KW, Sussman NM. Effects of differing dosages of vigabatrin (Sabril) on cognitive abilities and quality of life in epilepsy. Epilepsia. 1995;36:164-173.
194. Ring HA, Crellin R, Kirker S, Reynolds EH. Vigabatrin and depression. J Neurol Neurosurg Psychiatry. 1993;56:925-928.
195. Gil R, Neau JP. Rapid aggravation of aphasia by vigabatrin. J Neurol. 1995;242:251-252.
196. Remy C. Clobazam in the treatment of epilepsy: a review of the literature. Epilepsia. 1994;35(suppl 5):S88-S91.
197. Schmidt D. Clobazam for treatment of intractable epilepsy: a critical assessment, Epilepsia. 1994;35(suppl 5):S92-S95.
198. McNamara JO. Excitatory amino acid receptors and epilepsy. Curr Opin Neurol Neurosurg. 1993;6:583-587.
199. Brodie MJ, Richens A, Yuen AW. Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy: UK Lamotrigine/ Carbamazepine Monotherapy Trial Group. Lancet. 1995;345:476-479.
200. Kalviainen R, Aikia M, Saukkonen AM, Mervaala E, Riekkinen PJ Sr. Vigabatrin vs carbamazepine monotherapy in patients with newly diagnosed epilepsy: a randomized, controlled study. Arch Neurol. 1995;52:989-996.
201. Browne TR, Kugler AR, Eldon MA. Pharmacology and pharmacokinetics of fosphenytoin. Neurology. 1996;46(suppl 1):S2-S7.
202. Luhdorf K, Jensen LK, Plesner AM. Epilepsy in the elderly: incidence, social function, and disability. Epilepsia. 1986;27:135-141.
203. Olson KR, Kearny TE, Dyer JE, Benowitz ML, Blanc PD. Seizures associated with poisoning and drug overdose. Am J Emerg Med. 1993;11:565-568.